However, other pathways downstream of EGFR, such as STAT3 and PKC (protein kinase C) signalling, also play a role in HNSCC development and therapy resistance, and we will examine these factors in future studies. The gene discussed is PRRT2; the disease is head and neck squamous cell carcinoma.